FASL Antikörper (AA 103-281)
Kurzübersicht für FASL Antikörper (AA 103-281) (ABIN7569250)
Target
Alle FASL Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 103-281
-
Verwendungszweck
- Anti-CD178/FASLG/TNFSF6 Polyclonal antibody
-
Aufreinigung
- Antigen affinity purification.
-
Immunogen
- E. coli - derived recombinant Human CD178 / FASLG / TNFSF6 (Gln103-Leu281).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
-
-
- FASL (Fas Ligand (TNF Superfamily, Member 6) (FASL))
-
Andere Bezeichnung
- CD178
-
Hintergrund
- Receptor-binding FasL ectodomain,APL,APT1LG1,FasL ICD,Fas antigen ligand,CD178,sFasL,CD95L,APTL,TNFSF6,Apoptosis antigen ligand,SPA,FASLG,FasL,SPPL2A-processed FasL form,Tumor necrosis factor ligand superfamily member 6,Soluble Fas ligand,Fas ligand,CD95 ligand,CD95-L,FASL,
-
UniProt
- P48023
-
Pathways
- Apoptose, EGFR Signaling Pathway, Production of Molecular Mediator of Immune Response, Positive Regulation of Endopeptidase Activity
Target
-